Intarcia Therapeutics

h
...
The layoffs have taken the staff from 125 to less than two dozen, the report says. CEO KG announced the layoffs to staff at an all-hands meeting today in the company’s Hayward, Calif. offices.

This spartan crew has been whittled down following round after round of layoffs as customers and regulators have wised up to the lies that the company has been publicly sharing. After once maxing out at nearly 800 employees in late 2016, the company now stands as a skeleton of its former self, though for the company’s leadership this represents an inevitability that is the least of their problems.
...
The company was once valued at $9 billion.

This is too funny
 






so one more ULT all day BS mtg. Started with a bitchy moany email from KG about how the ULT is not being one team and the lack of trust. KG if you have people like SZ in hayweird and JS and SG in Boston how are you going to build trust? Trust comes from good people and not because you demand loyalty and get it! Open ur eyes.
 
























Pharmaceutical Companies and Whistleblower Policy Regarding Securities Fraud
Before a pharmaceutical or biotech company can sell a drug in the United States, the drug must be submitted to specific clinical trials and must clearly and objectively report the results to the Food and Drug Administration (FDA). A pharmaceutical company must prove to the FDA’s satisfaction that the new drug candidate is safe and effective. Even after approval of a drug by the FDA, a pharmaceutical company must report all information and data in its possession that may negatively impact a drug’s safety and efficacy profile.

In the past decade, many securities fraud cases have been brought against pharmaceutical companies and biotech companies when the public has become aware that a pharmaceutical company failed to disclose to the FDA negative information or even incomplete information relating to clinical trials of drug candidates. Each new drug can be worth billions of dollars in profit to a pharmaceutical company so at times the stock price of the pharmaceutical company can decrease dramatically once the disclosure is made public.

Pharmaceutical insiders – scientists, mathematicians, or any employee with original information- can now serve as whistleblowers and anonymously report a pharmaceutical company to the SEC for that company’s improper disclosure of data and information relating to drug candidates when in clinical trials or even after FDA approval.
 












TICK TICK TICK TICK

September 28, 2017 09:38 AM

FDA rejects Intarcia’s hotly promoted diabetes drug/device, citing manufacturing issues

TICK TICK TICK TICK

February 3, 2018 11:36 AM
Slammed by a trial hold, Intarcia terminates studies and axes staff in wake of an FDA rejection

TICK TICK TICK TICK

?? Intarcia to resubmit by March 2018 ???
 
























Is it really as bad as they say inside ? Got a call for a phone screen and it went well. Now I’m wondering if this is a place with a future. Is the approval this year or not ?
 






Is it really as bad as they say inside ? Got a call for a phone screen and it went well. Now I’m wondering if this is a place with a future. Is the approval this year or not ?

It's much worse. Bunch of gustpos there and thus I'm posting outside the company during lunch time.

PS - go read glassdoor pal
 






Oh hear, oh hear! Next up in the prison is Elizabeth Holmes and who will join Martin the Pharma Bro in NJ from Intarcia?

PS - don't drop the soap! :D:p

Pharma bro fraudster Martin Shkreli sent to federal prison in New Jersey after being denied minimum security camp
  • Martin Shkreli was sent to the low-security prison in Fort Dix, New Jersey, to serve the remainder of his seven-year sentence.
  • The "pharma bro" Shkreli was convicted of defrauding hedge-fund investors and of manipulating the stock of his former drug firm, Retrophin.
  • Shkreli gained notoriety in 2015 for hiking the price of the drug Daraprim by more than 5,000 percent while heading another pharmaceuticals company.
 


















But there has to be approval this year. No new studies needed a simple resubmission... WTF DO YOU MEAN NO APPROVAL ?????

You're such a schmuck... Still believe what KG says? Still believe in unicorns? Don't you know it's all charade under duress? Just resubmit pile of crap like the original NDA but the Feds are well aware of the antics and won't be fooled again - nice try SZ and KG.
 






How dare you make these nasty troll comments. KG inspires us everyday because he is right there with us making the call on what to do. We would be lost with out Kurt's leadreship and shining eample.
 






“With HIV, you can’t afford to have a day that you’re not treated,” said Graves of the importance of proper HIV treatment. “If your exposed to HIV, you’re going to get it.”

Pump boi sez majik pump make it so you no get HIV - if you healthy- you get majik pump - prevents HIV for three years

Graves explained that Intarcia’s chemists have developed a way to keep medications effective in a person’s body for over three years, which he described as “the enabling secret sauce of our company.”
 






“With HIV, you can’t afford to have a day that you’re not treated,” said Graves of the importance of proper HIV treatment. “If your exposed to HIV, you’re going to get it.”

Pump boi sez majik pump make it so you no get HIV - if you healthy- you get majik pump - prevents HIV for three years

Graves explained that Intarcia’s chemists have developed a way to keep medications effective in a person’s body for over three years, which he described as “the enabling secret sauce of our company.”

LOL LIES

Say whatever happened to the IPO in 2016, approval in 2016 and biggest lie of all 1 year ITCA implant for years that does not exist?